| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CDTX (CDTX) has 13 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. CDTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.65M | $465.23 | - | |
| CFO | 43.1K | $9.55M | - | |
| Other | 8.3K | $1.85M | - | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2019 | Abdollahian Neil | Chief Business Officer | Sell | 2,300 | $2.44 | $5,612.00 | -7.0% | |
| Mar 7, 2019 | Daruwala Paul58 | Chief Operating Officer | Sell | 2,240 | $2.55 | $5,713.57 | -4.3% | |
| May 23, 2018 | Stein Jeffrey | President &CEO | Buy | 212,766 | $4.70 | $1,000,000.20 | +383.0% | |
| Nov 15, 2017 | Biotech Target N V55 | 10% Owner | Buy | 60,000 | $7.57 | $453,966.00 | +2.7% | |
| Sep 12, 2017 | Stein Jeffrey | President &CEO | Buy | 7,350 | $6.79 | $49,906.50 | +16.5% | |
| Jun 7, 2017 | Sandison Taylor45 | Chief Medical Officer | Buy | 20,000 | $5.90 | $118,000.00 | +166.0% | |
| Jun 5, 2017 | Stein Jeffrey | President &CEO | Buy | 15,000 | $5.95 | $89,211.00 | +50.8% | |
| Mar 31, 2017 | Stein Jeffrey | President &CEO | Buy | 12,900 | $7.75 | $99,975.00 | +90.2% | |
| Mar 31, 2017 | Forrest Kevin | Chief Scientific Officer | Buy | 12,500 | $7.75 | $96,875.00 | +20.9% | |
| May 20, 2016 | Stein Jeffrey | President &CEO | Buy | 4,310 | $11.51 | $49,608.10 | +2.2% |